Water Island Capital’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Buy
+60,000
New +$429K 0.04% 80
2025
Q4
Sell
-10,372
Closed -$64.1K 93
2025
Q3
$64.1K Buy
+10,372
New +$67.8K 0.01% 83
2023
Q4
Sell
-22,650
Closed -$203K 60
2023
Q3
$203K Buy
22,650
+2,900
+15% +$31.2K 0.02% 73
2023
Q2
$244K Sell
19,750
-3,916
-17% -$41.9K 0.02% 67
2023
Q1
$220K Buy
23,666
+166
+0.7% +$1.72K 0.02% 69
2022
Q4
$247K Buy
23,500
+12,800
+120% +$163K 0.02% 75
2022
Q3
$194K Sell
10,700
-3,841
-26% -$58.1K 0.01% 81
2022
Q2
$206K Buy
+14,541
New +$241K 0.01% 77

Other funds holding AURA

Water Island Capital's AURA Position: Q2 2026 in Review

Water Island Capital opened a new position in Aura Biosciences (AURA) in Q2 2026: 60,000 shares worth $426K. The stake represents 0.04% of the portfolio and ranks #80 among its holdings. This is a return to the name: Water Island Capital previously reported a position in AURA as recently as Q3 2025.

Water Island Capital first reported a position in AURA in Q2 2022 and has held it in 8 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Water Island Capital held 60,000 shares of Aura Biosciences worth $426K as of Q2 2026.
  • Aura Biosciences was a new Water Island Capital position in Q2 2026.
  • Aura Biosciences made up 0.04% of Water Island Capital's portfolio in Q2 2026, its #80 holding.
  • Water Island Capital first reported a position in Aura Biosciences in Q2 2022 and has held it in 8 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Water Island Capital's 13F filing for Q2 2026, filed 14 Aug 2026.